Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods

被引:67
作者
Cheow, Wean Sin [1 ]
Hadinoto, Kunn [1 ]
机构
[1] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore
关键词
Nanoparticle; Encapsulation; Nanoprecipitation; Emulsification; Polymer; Biofilm; IN-VIVO ACTIVITIES; POLYMERIC NANOPARTICLES; PLGA NANOPARTICLES; PULMONARY DELIVERY; RELEASE; DRUG; VITRO; NANOPRECIPITATION; LEVOFLOXACIN; PENETRATION;
D O I
10.1016/j.colsurfa.2010.08.050
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070305 [高分子化学与物理];
摘要
Effective encapsulations of drugs that are highly soluble in both water and organic solvents are notoriously difficult to achieve using standard nanoparticle preparation methods, such as nanoprecipitation (NPC), single (ESE), and double (DESE) emulsification-solvent-evaporation methods. Modifications of the standard preparation methods are therefore needed to enhance encapsulation efficiency of this group of drugs. The present work investigates the feasibility of enhancing the encapsulation efficiency of highly water and solvent-soluble levofloxacin, which is widely used in antibiotic therapy against pulmonary biofilm infections, into poly(lactic-co-glycolic acid) (i.e. PLGA) nanoparticles. In addition, the nanoparticles are evaluated in terms of their drug loading, size, production yield, and in-vitro drug release profile. Lecithin inclusion into the aqueous phase in the ESE method results in two-fold improvements in the encapsulation efficiency and drug loading (i.e. 23% and 2.3%, w/w, respectively) compared to the standard method. Similar results are obtained when the water-miscibility level of the oil phase is increased in the DESE method. Importantly, these nanoparticles possess size approximate to 200-300 nm and biphasic extended drug release profiles suitable for anti-biofilm therapy. Lastly, the nanoparticles can be readily transformed into inhalable solid dosage forms without jeopardizing their drug loadings and antibacterial activities. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 22 条
[1]
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[2]
Antibacterial Efficacy of Inhalable Levofloxacin-Loaded Polymeric Nanoparticles Against E. coli Biofilm Cells: The Effect of Antibiotic Release Profile [J].
Cheow, Wean Sin ;
Chang, Matthew Wook ;
Hadinoto, Kunn .
PHARMACEUTICAL RESEARCH, 2010, 27 (08) :1597-1609
[3]
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles [J].
Cohen-Sela, Einat ;
Chorny, Michael ;
Koroukhov, Nickolay ;
Danenberg, Haim D. ;
Golomb, Gershon .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (02) :90-95
[4]
Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method -: art. no. 68 [J].
Eerikäinen, H ;
Peltonen, L ;
Raula, J ;
Hirvonen, J ;
Kauppinen, EI .
AAPS PHARMSCITECH, 2004, 5 (04)
[5]
Biopharmaceutical characterization of oral immediate release drug products.: In vitro in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin [J].
Frick, A ;
Möller, H ;
Wirbitzki, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (03) :305-311
[6]
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug [J].
Govender, T ;
Stolnik, S ;
Garnett, MC ;
Illum, L ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) :171-185
[7]
Hollow spherical nanoparticulate aggregates as potential ultrasound contrast agent: shell thickness characterization [J].
Hadinoto, Kunn ;
Cheow, Wean Sin .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (10) :1167-1179
[8]
Mechanical stability of hollow spherical nano-aggregates as ultrasound contrast agent [J].
Hadinoto, Kunn .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 374 (1-2) :153-161
[9]
Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa [J].
Halwani, Majed ;
Hebert, Stephanie ;
Suntres, Zacharias E. ;
Lafrenie, Robert M. ;
Azghani, Ali O. ;
Omri, Abdelwahab .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 373 (1-2) :141-146
[10]
The use of microscopy and three-dimensional visualization to evaluate the structure of microbial biofilms cultivated in the Calgary Biofilm Device [J].
Harrison, Joe J. ;
Ceri, Howard ;
Yerly, Jerome ;
Stremick, Carol A. ;
Hu, Yaoping ;
Martinuzzi, Robert ;
Turner, Raymond J. .
BIOLOGICAL PROCEDURES ONLINE, 2006, 8 (1) :194-215